Cogent Biosciences is a biotechnology company that is dedicated to developing precision therapies for genetically defined diseases. With a focus on rational precision therapies, they aim to tackle the underlying drivers of diseases and provide genuine hope for patients. The company recognizes the significant unmet need in treating diseases caused by genetic mutations, such as cancers, autoimmune conditions, and rare diseases.

They strive to extend patient survival and improve their quality of life. Using a patient-centric approach, Cogent employs a world-class discovery organization to develop novel precision therapies in diseases where the cause is well understood and directly linked to genetic mutations. They aim to improve upon existing drugs and create breakthrough solutions for diseases that have not yet been adequately addressed.

Cogent Biosciences is committed to transforming the lives of patients with unmet medical needs through their passionate and dedicated team